The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 07, 2023

Filed:

Jan. 19, 2022
Applicant:

Matthias W Rath, Henderson, NV (US);

Inventors:

Aleksandra Niedzwiecki, Henderson, NV (US);

Matthias W Rath, Henderson, NV (US);

Vadim Ivanov, Castro Valley, CA (US);

Waldemar Sumera, Sanjose, CA (US);

Assignee:

Other;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/55 (2006.01); A61P 9/12 (2006.01); A61K 31/375 (2006.01); A61K 31/4415 (2006.01); A61K 31/51 (2006.01); A61K 31/525 (2006.01); A61K 31/593 (2006.01); A61K 31/714 (2006.01); A61K 36/23 (2006.01); A61K 36/61 (2006.01); A61K 36/87 (2006.01);
U.S. Cl.
CPC ...
A61K 38/556 (2013.01); A61K 31/375 (2013.01); A61K 31/4415 (2013.01); A61K 31/51 (2013.01); A61K 31/525 (2013.01); A61K 31/593 (2013.01); A61K 31/714 (2013.01); A61K 36/23 (2013.01); A61K 36/61 (2013.01); A61K 36/87 (2013.01); A61P 9/12 (2018.01);
Abstract

A micronutrient composition is highly effective in controlling high blood pressure while given to mammal for treating with or without prescribed pharmaceutical drug. The micronutrient composition comprises of vitamin C, vitamin D3, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B9 and vitamin B12 and calcium and magnesium, clove extract, grape extract, celery extract and L-arginine. This micronutrient composition supports critical cellular mechanisms involved in the relaxation of vascular smooth muscle cells important in maintaining healthy blood pressure. The combined effects of the micronutrients contained in the micronutrient composition include increased production of NO 'relaxing factor' and decreased activity of Angiotensin converting enzyme 1 (ACE1). ACE1 inhibitory effect of this natural formula was more pronounced than obtained with the pharmaceutical ACE1 inhibitor—Lisinopril—the commonly prescribed high blood pressure medication.


Find Patent Forward Citations

Loading…